Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
ChemoMetec
ISIN DK0060055861
|WKN A0MS80
Market cap (in EUR)
881 m
Country
Denmark
Sector
Healthcare
Dividend yield
1.85%
Overview
Description
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. It operates through the following segments: Instruments, Consumer Goods, Service, and Others. The Instruments segment sells NucleoCounter NC-100, NC-200, NC250, and NC-3000. The Consumer Goods segment offers disposable cartridges, disposable analysis chambers, reagents, and test kits. The Service segment provides service packages and its corresponding guarantees. The Others segment offers measuring modules and accessories. The company was founded by Hans Martin Glensbjerg in 1997 and is headquartered in Allerod, Denmark.
Healthcare Healthcare Services Miscellaneous Healthcare Denmark
Financials
Key metrics
| Market capitalisation, EUR | 881 m |
| EPS, EUR | - |
| P/B ratio | 10.1 |
| P/E ratio | 37.2 |
| Dividend yield | 1.85% |
Income statement (2025)
| Revenue, EUR | 66 m |
| Net income, EUR | 25 m |
| Profit margin | 37.61% |
What ETF is ChemoMetec in?
There are 22 ETFs which contain ChemoMetec. All of these ETFs are listed in the table below. The ETF with the largest weighting of ChemoMetec is the iShares Healthcare Innovation UCITS ETF.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.